References
- Bordier P., Rasmussen H., Marie P., Miravet L., Gueris J., Ryckwaert A. Vitamin D metabolites and bone mineralization in man. J. clin. Endocrinol. Metab. 1978; 46: 284
- Chesney R. W., Rosen J. F., Hamstra A. J., Smith C., Mahaffey K., DeLuca H. F. Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J. clin. Endocrinol. Metab. 1981; 53: 139
- Christensen M. S. A sensitive radioimmunoassay of parathyroid hormone in human serum using a specific extraction procedure. Scand. J. clin. Lab. Invest. 1976; 36: 313
- Christiansen C., Roedbro P. Estimation of total body calcium from the bone mineral content of the forearm. Scand. J. clin. Lab. Invest. 1975; 35: 425
- Faber O. K., Binder C. C-peptide response to glucagon. A test for the residual-cell function in diabetes mellitus. Diabetes 1977; 26: 605
- Galus K., Szymendera J., Zaleski A., Schreyer K. Effects of 1 α-hydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on bone remodelling. Calc. Tiss. Int. 1980; 31: 209
- Heath H., III, Lambert P. W., Service F. J., Arnaud S. B. Calcium homeostasis in diabetes mellitus. J. clin. Endocrinol. Metab. 1979; 49: 462
- Kahn A. J., Malone J. D., Teitelbaum S. L. Effects of human calcitonin (HCT) and 1,25-dihydroxy D3 (1,25(OH)2D3) on macrophage-mediated bone resorption. Clin. Res. 1979; 27: 656A
- Levin M. E., Boisseau V. C., Avioli L. V. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N. Engl. J. Med. 1976; 294: 241
- McNair P., Christiansen C., Christensen M. S., Madsbad S., Faber O. K., Binder C., Transboel I. Development of bone mineral loss in insulin treated diabetes: A 1½ years follow-up study in 60 patients. Eur. J. clin. Invest. 1981; 11: 55
- McNair P., Madsbad S., Christiansen C., Christensen M. S., Faber O. K., Binder C., Transboel I. Bone loss in diabetes: Effects of metabolic state. Diabetologia 1979; 17: 283
- McNair P., Madsbad S., Christiansen C., Faber O. K., Transboel I., Binder C. Osteopenia in insulin treated diabetes mellitus. Its relation to age at onset, sex and duration of disease. Diabetologia 1978; 15: 87
- Ornoy A., Goodwin D., Noff D., Edelstein S. 24,25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation. Nature 1978; 276: 517
- Ringe J. D., Kuhlencordt F., Kuehnau J., Jr. Mineralgehalt des Skeletts bei Langzeitdiabetikern. Densitometrischer Beitrag zur ‘Osteopathia Diabetica’. Dtsch. Med. Wochenschr. 1976; 101: 280
- Schneider L. E., Schedl H. P., McCain T., Haussler M. R. Experimental diabetes reduces circulating 1,25-di-hydroxyvitamin D in the rat. Science 1977; 196: 1452
- Shepard P. M., Horst R. L., Jorgensen N. A., DeLuca H. F. Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem. J. 1979; 182: 55
- Spencer E. M., Khalil M., Tobiassen O. Experimental diabetes in the rat causes an insulin-reversible decrease in renal 25-hydroxyvitamin D3-1 α-hydroxylase activity. Endocrinol. 1980; 107: 300
- Sulimovici S., Roginsky M. S. Hepatic metabolism of vitamin D3 in streptozotocin-induced diabetic rat. Acta Endocrinol. 1980; 93: 346
- Tjellesen L., Nielsen B., Christiansen C. Seasonal fluctuations in serum concentrations of vitamin D metabolites. Br. Med. J. 1982; 284: 196
- Wu K., Schubeck K. E., Frost H. M., Villanueva A. Haversian bone formation rates determined by a new method in a mastodon, and in human diabetes mellitus and osteoporosis. Calc. Tiss. Res. 1970; 6: 204